In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers by Caskey M, Trumpfheller C, Pollak S, Sinnenberg L, Hurley A, Pring J, Shimeliovich I, Yipp B, Anandasabapathy N, Mehandru S, Sarma P, Koup R, Bailer R, Tomaras G, Sato A, Keler T, Steinman R, Schlesinger S

Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo by Lu, C.-L., Bournazos, S., Schoofs, T., Halper-Stromberg, A., Horwitz, J. A., Nogueira, L., Golijanin, J., Gazumyan, A., Ravetch, J. V., Caskey, M., Nussenzweig, M. C., Murakowski, Dariusz Krzysztof, Chakraborty, Arup K, Sarkar, Debolina

Get full text
Get full text
Get full text

OA05-01. <it>In vivo </it>electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers by Park H, Schmidt C, Smith C, Dally L, Clark L, Cheeseman H, Gill DK, Tarragona T, Cox J, Huang Y, Andersen J, Caskey M, Vittorino RM, Boente-Carrera MM, Dugin DP, Gardiner DF, Hannaman D, Schlesinger SJ, Hurley A, Vasan S, Sayeed E, Gilmour J, Fast P, Bernard R, Ho DD